Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oncology Institute (TOI) Tax Provisions (2020 - 2025)

Oncology Institute (TOI) has disclosed Tax Provisions for 5 consecutive years, with -$131000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Tax Provisions changed N/A year-over-year to -$131000.0, compared with a TTM value of -$131000.0 through Sep 2025, up 58.28%, and an annual FY2023 reading of -$36000.0, up 85.19% over the prior year.
  • Tax Provisions was -$131000.0 for Q2 2025 at Oncology Institute, up from -$314000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $799000.0 in Q3 2021 and bottomed at -$2.5 million in Q4 2021.
  • Average Tax Provisions over 4 years is -$83153.8, with a median of $44000.0 recorded in 2023.
  • The sharpest move saw Tax Provisions skyrocketed 6254.89% in 2021, then crashed 104.1% in 2022.
  • Year by year, Tax Provisions stood at -$2.5 million in 2021, then soared by 85.13% to -$367000.0 in 2022, then grew by 14.44% to -$314000.0 in 2023, then skyrocketed by 58.28% to -$131000.0 in 2025.
  • Business Quant data shows Tax Provisions for TOI at -$131000.0 in Q2 2025, -$314000.0 in Q4 2023, and $135000.0 in Q3 2023.